InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
10
T+90 hit rate
0%
T+90 mean return
-24.2%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Brumm Joshua T, Executive. Insider active across 3 companies, notably Dyne Therapeutics, Inc.. Cumulatively, 27 disclosures have been logged. Split: 0 buy · 10 sells. Total volume traded: €680k. History available since 20 September 2021. The latest transaction was filed on 8 March 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations27 total
42,305 sharesOrdinary SharesSEC:0001628280-26-044884:0
153,931 shares@ US$5.5443.8% of flowCommon StockSEC:0000950170-24-030479:0
9,086 shares@ US$25.8512.1% of flowCommon StockSEC:0000950170-24-029616:0
5,520 shares@ US$5.541.6% of flowCommon StockSEC:0000950170-24-024300:0
20,000 shares0Common StockSEC:0000950170-24-009406:0
51,183 shares@ US$1.032.7% of flowCommon StockSEC:0000950170-24-002280:0
7,585 shares@ US$10.724.2% of flowCommon StockSEC:0001209191-23-058327:0
358,877 shares0Common StockSEC:0001209191-23-055523:0
12,032 shares@ US$9.4116.7% of flowCommon StockSEC:0001209191-23-050169:0
7,672 shares@ US$10.414.2% of flowCommon StockSEC:0001209191-23-049357:0
20,000 shares0Common StockSEC:0001209191-23-036544:0
7,318 shares@ US$13.335.1% of flowCommon StockSEC:0001209191-23-018978:0
144,000 shares0Common StockSEC:0001209191-22-060966:0
14,200 shares@ US$1.030.8% of flowCommon StockSEC:0001209191-22-053212:0
11,836 shares@ US$13.709.1% of flowCommon StockSEC:0001209191-22-050884:0
3,480 shares@ US$14.052.8% of flowCommon StockSEC:0001209191-22-050119:0
24,118 shares0Common StockSEC:0001209191-22-041330:0
3,540 shares@ US$4.950.0006% mcap12.5% of flowCommon StockSEC:0001209191-22-037143:0
3,384 shares@ US$8.730.0009% mcap19.9% of flowCommon StockSEC:0001209191-22-018532:0
118,190 shares0Common StockSEC:0001209191-21-069420
118,190 shares0Common StockSEC:0001209191-21-069420:0
3,500 shares0Common StockSEC:0001209191-21-059052:0
3,500 shares0Common StockSEC:0001209191-21-059052
3,425 shares@ US$15.610.0016% mcap33.8% of flowCommon StockSEC:0001209191-21-057324:0
3,425 shares@ US$15.612.6% of flowCommon StockSEC:0001209191-21-057324
25 of 27 declarations
About Brumm Joshua T
Joshua T. Brumm is an Executive at Dyne Therapeutics, Inc. He contributes to the strategic direction of the company, bringing his expertise in management and business development. His role is essential in supporting Dyne's mission and objectives.
